What changed in this update
The shot, made by Moderna, will be available for this year's upcoming flu season.
The mFlusiva vaccine for older people is the first made with the mRNA platform key to ending the coronavirus pandemic The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the Covid -19 pandemic, Moderna, the manufacturer, said. The shot, named mFlusiva, is intended for adults aged 50 or older. Other brands of flu…
NYTimes – Business The shot, made by Moderna, will be available for this year's upcoming flu season.
The shot, made by Moderna, will be available for this year's upcoming flu season.
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.
NYTimes – Business The agency had initially refused to even review the application but reversed course after a public outcry.
Explore stories gaining momentum and continuing events with new developments.